ReNTOX 200U — Botulinum Toxin Type A (200 Units/Vial)
- 200 units of botulinum toxin type A per vial — lyophilized powder (Hall strain, ATCC 3502)
- 99.97% purity with 227 U/ng specific potency; protein load 0.44 ng/100 U — among the lowest in its class
- 927 kDa complex with 150 kDa core neurotoxin; low-diffusion profile for precise 3D contouring
- Clinically validated: Phase 3 trial with 86.89% improvement rate in glabellar lines
- Standard dilution: 5 mL preservative-free 0.9% saline per 200 U → 4 U / 0.1 mL
- Use within 24 hours after reconstitution at 2–8°C; cold-chain required
- Origin: South Korea; regulated professional product for licensed healthcare professionals only
| 1 – 2 boxes | $51.40 / box |
| 3 – 9 boxes | $48.83 / box |
| 10 – 19 boxes | $46.26 / box |
| 20 – 29 boxes | $44.72 / box |
| 30+ boxes | Contact for quote |
What Is ReNTOX 200U — Botulinum Toxin Type A (200 Units/Vial)?
An ultra-high-purity botulinum toxin type A (200 units per vial) supplied as a lyophilized powder for professional injection. Produced from the Hall strain (ATCC 3502) with a 927 kDa complex and 150 kDa core neurotoxin, it achieves 99.97% purity and temporarily relaxes targeted muscles by blocking acetylcholine release, improving moderate-to-severe glabellar lines and supporting larger multi-zone facial and therapeutic treatment protocols.
ReNTOX 200U is an ultra-high-purity botulinum toxin type A supplied as a lyophilized powder in a transparent glass vial. Produced from the Hall strain (ATCC 3502), it is formulated as a 927 kDa complex with a 150 kDa core neurotoxin, achieving 99.97% purity and a specific potency of 227 U/ng — the same as an established high-purity reference toxin — with a protein load of just 0.44 ng per 100 U, among the lowest in its class. Its low-diffusion profile supports precise 3D contouring of the masseter, corrugator and orbicularis muscles without spreading to adjacent groups. Following injection, the toxin cleaves SNAP-25 and blocks acetylcholine release so the treated muscle relaxes and dynamic wrinkles become visibly shallower. Clinically validated in a Phase 3 trial with an 86.89% improvement rate in glabellar lines. The 200-unit presentation suits practitioners managing larger treatment volumes — multi-zone facial sessions, bilateral masseter contouring and full-face protocols. Cold-chain shipping (2–8°C) is required from manufacturer to clinic. Supplied to licensed healthcare professionals only.
Specifications
| Product name | ReNTOX 200U |
|---|---|
| Product type | Botulinum toxin type A neurotoxin complex — lyophilized powder for injection |
| Active ingredient | Clostridium botulinum toxin type A (Hall strain, ATCC 3502), 200 units per vial |
| Presentation | 1 vial × 200 units per box (lyophilized powder) |
| Purity | 99.97%; specific potency 227 U/ng; protein load 0.44 ng/100 U |
| Excipients | Human serum albumin 1.0 mg, sodium chloride 1.8 mg |
| Mechanism of action | Cleaves SNAP-25, blocking acetylcholine release at the neuromuscular junction and temporarily relaxing treated muscles |
| Indication | Temporary improvement of moderate-to-severe glabellar lines in adult patients aged 19–65 |
| Treatment areas | Glabellar lines, forehead lines, crow's feet, masseter contouring, platysma bands, hyperhidrosis |
| Onset of action | 3–5 days (typical clinical range) |
| Duration of effect | 4–8 months (dose- and area-dependent) |
| Reconstitution | Preservative-free 0.9% sodium chloride (5 mL per 200 U → 4 U / 0.1 mL) |
| Storage | 2–8°C in hermetic container, protected from light; do not freeze (cold-chain required) |
| Shelf life | 36 months (unopened) |
| Use after reconstitution | Within 24 hours at 2–8°C |
| Origin | South Korea |
Key Benefits
- Economical 200-unit vial — ideal for multi-zone facial treatments, larger muscle groups and higher-dose protocols
- 99.97% ultra-high purity with the lowest protein load in its class — reduced immunogenicity risk for repeat treatments
- 227 U/ng specific potency — same as an established high-purity reference toxin
- Low-diffusion profile supports precise muscle targeting and natural-looking 3D contouring results
- Backed by a Phase 3 clinical trial with an 86.89% improvement rate
- Reliable, predictable muscle relaxation that preserves facial expression
Suggested Treatment Protocol
For professional use only. Reconstitute with preservative-free 0.9% sodium chloride (standard: 5 mL per 200 U vial, yielding 4 U per 0.1 mL). Inject the saline slowly down the inner vial wall — do not shake — and gently swirl until the powder is fully dissolved. The solution should be clear and free of particles; use within 24 hours when stored at 2–8°C. Glabellar lines: 20 U total — 0.1 mL (4 U) at each of five points (two per corrugator muscle and one in the procerus muscle), using a 30-gauge needle. Forehead lines: 10–20 U across 4–6 injection points. Crow's feet: 12–15 U per side across 3 injection points. Masseter contouring and therapeutic dosing follow individual clinical protocols. Avoid diffusion into the levator palpebrae superioris and zygomaticus major. Contraindicated in patients with hypersensitivity to any component, neuromuscular disorders, and during pregnancy or lactation. Avoid concomitant use of aminoglycosides or agents interfering with neuromuscular transmission.
Frequently Asked Questions
What is ReNTOX 200U?
ReNTOX 200U is an ultra-high-purity botulinum toxin type A (200 units per vial) supplied as a lyophilized powder. It temporarily relaxes treated muscles by blocking acetylcholine release, making dynamic wrinkles such as glabellar lines visibly shallower.
What makes ReNTOX different from other botulinum toxin type A products?
ReNTOX achieves 99.97% purity with a specific potency of 227 U/ng and a protein load of just 0.44 ng per 100 U — among the lowest in its class — reducing immunogenicity risk for repeat treatments. Its low-diffusion profile also supports precise muscle targeting for natural-looking 3D contouring.
How is ReNTOX 200U reconstituted?
Reconstitute with preservative-free 0.9% sodium chloride — the standard dilution for a 200 U vial is 5 mL, yielding 4 U per 0.1 mL. Inject the saline slowly down the inner vial wall, do not shake, and gently swirl until fully dissolved. Use within 24 hours when stored at 2–8°C.
When do results appear and how long do they last?
Onset of action typically occurs within 3–5 days, with the full effect visible around 2 weeks. Results usually last 4–8 months depending on the treated area, dosage and individual metabolism.
What is the 200-unit presentation used for?
The 200-unit vial suits practitioners managing larger treatment volumes: multi-zone facial sessions, bilateral masseter contouring and full-face protocols, while still covering standard glabellar (20 U), forehead (10–20 U) and crow's feet (12–15 U per side) protocols.
Do you offer wholesale pricing?
Yes. Volume discounts apply: 3–9 boxes 5% off, 10–19 boxes 10% off, 20–29 boxes 13% off, and 30+ boxes contact us for a quote.
ReNTOX 200U is excellent value for multi-zone sessions — the 5 mL reconstitution to 4 U / 0.1 mL keeps dosing consistent across glabellar, forehead and masseter work. The ultra-low protein load is reassuring for repeat patients, and results held for months.
The 200-unit vial is my go-to for full-face protocols. The lyophilized powder dissolved cleanly, the low-diffusion profile gave precise, natural-looking results, and the cold-chain packaging arrived perfectly intact. Highly recommended alongside the 100-unit size.
Please log in to leave a review.